Viewing Study NCT03251300


Ignite Creation Date: 2025-12-26 @ 12:19 PM
Ignite Modification Date: 2026-02-25 @ 7:06 PM
Study NCT ID: NCT03251300
Status: UNKNOWN
Last Update Posted: 2023-03-29
First Post: 2017-08-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
Sponsor: Far Eastern Memorial Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Overactive Bladder Syndrome View
Keywords: